###begin article-title 0
PD-1 Regulates Neural Damage in Oligodendroglia-Induced Inflammation
###end article-title 0
###begin p 1
Conceived and designed the experiments: AK MM HW RM. Performed the experiments: AK NS CWI CL. Analyzed the data: AK NS CWI CL HW RM. Contributed reagents/materials/analysis tools: CL KAN HW RM. Wrote the paper: AK HW RM.
###end p 1
###begin p 2
Current address: Caritas-Krankenhaus Bad Mergentheim, Bad Mergentheim, Germany
###end p 2
###begin p 3
###xml 159 164 <span type="species:ncbi:10090">mouse</span>
###xml 810 814 <span type="species:ncbi:10090">mice</span>
We investigated the impact of immune regulatory mechanisms involved in the modulation of the recently presented, CD8+ lymphocyte mediated immune response in a mouse model of oligodendropathy-induced inflammation (PLPtg-mutants). The focus was on the role of the co-inhibitory molecule PD-1, a CD28-related receptor expressed on activated T- and B-lymphocytes associated with immune homeostasis and autoimmunity. PLPtg/PD-1-deficient double mutants and the corresponding bone marrow chimeras were generated and analysed using immunohistochemistry, light- and electron microscopy, with particular emphasis on immune-cell number and neural damage. In addition, the immune cells in both the CNS and the peripheral immune system were investigated by IFN-gamma elispot assays and spectratype analysis. We found that mice with combined pathology exhibited significantly increased numbers of CD4+ and CD8+ T-lymphocytes in the CNS. Lack of PD-1 substantially aggravated the pathological phenotype of the PLPtg mutants compared to genuine PLPtg mutants, whereas the PD-1 deletion alone did not cause alterations in the CNS. CNS T-lymphocytes in PLPtg/PD-1-/- double mutants exhibited massive clonal expansions. Furthermore, PD-1 deficiency was associated with a significantly higher propensity of CNS but not peripheral CD8+ T-cells to secrete proinflammatory cytokines. PD-1 could be identified as a crucial player of tissue homeostasis and immune-mediated damage in a model of oligodendropathy-induced inflammation. Alterations of this regulatory pathway lead to overt neuroinflammation of high pathogenetic impact. Our finding may have implications for understanding the mechanisms leading to the high clinical variability of polygenic or even monogenic disorders of the nervous system.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 378 381 378 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Ip1">[1]</xref>
###xml 728 731 728 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Crocker1">[2]</xref>
###xml 928 931 928 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Ip2">[3]</xref>
###xml 1134 1137 1134 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Leder1">[4]</xref>
###xml 1418 1421 1418 1421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Lucchinetti1">[5]</xref>
###xml 1423 1426 1423 1426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Barnett1">[6]</xref>
###xml 1594 1597 1594 1597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Warshawsky1">[7]</xref>
###xml 1599 1602 1599 1602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Gorman1">[8]</xref>
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
###xml 912 927 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1524 1530 <span type="species:ncbi:9606">humans</span>
We have recently investigated a mouse myelin mutant overexpressing the proteolipid protein (PLP) in oligodendrocytes leading to myelin degeneration and late onset axonal degeneration. Although being primarily caused by the glial mutation, the neuropathological phenotype was accompanied by an elevation of CD11b+ macrophages and CD8+ T-lymphocytes in the central nervous system [1]. Reconstitution experiments with RAG-1 deficient myelin mutants, receiving bone-marrow from either CD8+/CD4- or CD8-/CD4+ mutants, clearly identified CD8+ T-lymphocytes cells as pathogenic mediators. Lack of the macrophage-restricted molecule sialoadhesin in the PLP mutants, that mediates interactions of macrophage-like cells and T-lymphocytes [2], abrogates the elevation of CD8+ T-lymphocytes and substantially ameliorates the myelin-phenotype of the PLP mutants, further supporting the pathogenetic role of CD8+ cells in PLP transgenic mice [3]. In this model, CD8+ lymphocytes show clonal expansions in the diseased CNS but not in peripheral lymphatic organs. This serves as a strong hint for a pathogenetic, antigen-specific role of these cells [4]. The link between oligodendrocyte damage and components of the adaptive immune system is particularly relevant for inflammatory disorders of the nervous system. It has been recently hypothesized that subtypes of multiple sclerosis (MS) may be caused by a primary oligodendropathy [5], [6]. This hypothesis is strongly supported by recent clinical reports, showing that PLP mutations in humans can be linked to primary progressive or relapsing-remitting MS [7], [8]. Thus, our recent work identifying a primary oligodendropathy as a "trigger" for immune-driven pathological changes is important for our understanding of pathomechanisms occurring in some forms of MS.
###end p 5
###begin p 6
###xml 139 142 139 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Hafler1">[9]</xref>
###xml 332 336 332 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Okazaki1">[10]</xref>
###xml 338 342 338 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Okazaki2">[11]</xref>
###xml 473 477 473 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Kroner1">[12]</xref>
###xml 692 696 692 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Schmid1">[13]</xref>
###xml 779 783 779 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Kroner2">[14]</xref>
It is well known, that genetic and environmental factors control disease onset and disease course of CNS inflammatory autoimmune disorders [9]. The co-inhibitory molecule "programmed death" (PD)-1 (CD279) is a CD28-related receptor expressed on activated T- and B-lymphocytes and associated with immune homeostasis and autoimmunity [10], [11]. Accordingly, we recently demonstrated that a polymorphism of the PD-1 gene is associated with a progressive disease course in MS [12], therefore corroborating the importance of PD-1 as a disease modifying gene. Moreover, inactivation of PD-1 in an animal model for inherited demyelination in the peripheral nervous system implicating T-lymphocytes [13] leads to a substantial aggravation of the primarily genetically-caused neuropathy [14].
###end p 6
###begin p 7
###xml 137 152 <span type="species:ncbi:10090">transgenic mice</span>
In the present study, we investigate the impact of immune-regulatory mechanisms involved in the modulation of the immune response in PLP transgenic mice, a model of oligodendropathy-induced inflammation. Our present study identifies PD-1 as a crucial factor regulating tissue homeostasis of T-lymphocytes and indicates that a primary oligodendropathy combined with alterations in this regulatory pathway can lead to accelerated neuroinflammatory reactions of high pathogenetic impact.
###end p 7
###begin title 8
Materials and Methods
###end title 8
###begin title 9
Animals and Determination of Genotypes
###end title 9
###begin p 10
###xml 20 24 20 24 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Readhead1">[15]</xref>
###xml 73 76 73 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Ip1">[1]</xref>
###xml 91 95 91 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Nishimura1">[16]</xref>
###xml 203 207 203 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Kroner2">[14]</xref>
###xml 4 19 <span type="species:ncbi:10090">transgenic mice</span>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
###xml 255 259 <span type="species:ncbi:10090">mice</span>
PLP transgenic mice [15] were bred and genotyped as described previously [1]. PD-1-/- mice [16] were kindly provided by T. Honjo and C. Blank. Absence of PD-1 was verified by PCR genotyping as described [14]. To generate double mutants, PLPtg and PD-1-/- mice were crossbred. All resulting genotypes were investigated at 2, 6 and 12 months of age.
###end p 10
###begin p 11
###xml 50 54 50 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Nishimura1">[16]</xref>
###xml 324 327 322 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Ip1">[1]</xref>
###xml 329 333 327 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Kroner2">[14]</xref>
###xml 335 339 333 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Kobsar1">[17]</xref>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
###xml 238 242 <span type="species:ncbi:10090">mice</span>
To exclude organ autoimmunity in the PD-1-/- mice [16], urine samples were investigated for protein and glucose with CombiScreen(R) urine tests (BioconDiagnostik, Voehl-Marienhagen, Germany). For bone marrow chimerization, PLPtg/RAG-1-/- mice were used as recipients. RAG-1 deficiency was identified as previously described [1], [14], [17].
###end p 11
###begin p 12
###xml 4 8 <span type="species:ncbi:10090">mice</span>
All mice were bred and kept in our animal facility under barrier conditions (University of Wuerzburg, Department of Neurology). All animal experiments were approved by the local authorities (Regierung von Unterfranken).
###end p 12
###begin title 13
Bone marrow chimerization
###end title 13
###begin p 14
###xml 570 573 570 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Ip1">[1]</xref>
###xml 575 579 575 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Murer1">[18]</xref>
###xml 581 585 581 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Mueller1">[19]</xref>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 116 120 <span type="species:ncbi:10090">mice</span>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
Two strategies to generate bone marrow chimeras were performed: In one group, the recipients (PLPtg mice with PLPwt mice as controls) were sublethally irradiated (5 Gy), while mice in the other group were deficient for the recombination activating gene (RAG)-1 (PLPtg/RAG-1-/- recipients with PLPwt/RAG-1-/- as controls). The bone marrow chimeras were transplanted with PD-1-/- or wildtype bone marrow at the age of 6-8 weeks and investigated at the age of 10 months (n = 8-9). Transplantation and control of successful transplantation was performed as described before [1], [18], [19].
###end p 14
###begin title 15
Purification of splenocytes
###end title 15
###begin p 16
###xml 144 145 144 145 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 147 149 147 149 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2,</sub>
###xml 160 161 160 161 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Spleens were passed through a cell strainer (BD Biosciences Pharmingen, San Jose, CA USA), erythrocytes were lysed with a lysis buffer (150mM NH4Cl2, 10 mM KHCO3, 0.1 mM EDTA in distilled water at pH 7.3) and cells were washed and processed for the respective experiments.
###end p 16
###begin title 17
Preparation of CNS mononuclear cells and flow cytometry of splenocytes and CNS lymphocytes
###end title 17
###begin p 18
###xml 24 25 24 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 168 171 168 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Ip1">[1]</xref>
###xml 238 241 238 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Leder1">[4]</xref>
###xml 243 247 243 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Magnus1">[20]</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were killed with CO2 and transcardially perfused with cold 0.1 M PBS. The CNS was prepared, tissues were homogenized and cells were gradient isolated as described [1]. Flow cytometry was performed using standard methods as described [4], [20].
###end p 18
###begin title 19
Tissue preparation and immunohistochemistry
###end title 19
###begin p 20
###xml 45 49 <span type="species:ncbi:10090">mice</span>
###xml 256 260 <span type="species:ncbi:10090">mice</span>
For identification of macrophage-like cells, mice were transcardially perfused with 4% paraformaldehyde in 0.1 M cacodylate buffer. Tissue was dissected, postfixed for 2 hours and cryoprotected in 30% sucrose overnight. For T- lymphocyte and MBP staining, mice were perfused with 0.1 M phosphate buffered saline (PBS) only. After snap freezing, 10 microm thick transverse sections of the spinal cord and longitudinal or transverse sections of the optic nerve were cut.
###end p 20
###begin p 21
###xml 97 100 97 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Ip1">[1]</xref>
###xml 102 105 102 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Ip2">[3]</xref>
###xml 283 286 279 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Ip1">[1]</xref>
###xml 288 291 284 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Ip2">[3]</xref>
Immunohistochemistry for CD11b, Sialoadhesin, CD4, CD8 and MBP was performed as described before [1], [3]. MBP was stained on optic nerve cross sections 1200-1400 microm caudal to the retina. Sources of reagents, of antibodies and clones of the antibodies were the same as described [1], [3].
###end p 21
###begin title 22
Assessment of demyelination
###end title 22
###begin p 23
Myelin damage in optic nerve cross sections was assessed by measuring MBP negative areas, data were displayed as a percentage of the total area. For this, we used a Zeiss Axiophot2 microscope at a final magnification of 300x. The area was measured using digital images acquired via a CCD- camera and ImagePro 4.0 software.
###end p 23
###begin p 24
###xml 77 80 77 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Ip1">[1]</xref>
Additionally, myelin damage was semiquantitatively rated as described before [1], with score 1 depicting homogeneous MBP distribution, score 5 massive myelin loss.
###end p 24
###begin title 25
Tissue preservation for light microscopy of semithin sections
###end title 25
###begin p 26
###xml 125 128 125 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Ip1">[1]</xref>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
Optic nerves from transcardially perfused mice were processed for light microscopy of semithin sections as recently reported [1]. Tissue damage was assessed by quantification of axonopathic vacuoles >6 microm.
###end p 26
###begin title 27
Quantification of immune cells in the CNS
###end title 27
###begin p 28
###xml 257 260 257 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Ip1">[1]</xref>
###xml 110 114 <span type="species:ncbi:10090">mice</span>
Longitudinal sections of the optic nerve of 2, 6 and 12 months old wildtype, PD-1-/-, PLPtg and PLPtg/PD-1-/- mice and 10 months old bone marrow chimeras were analysed. Quantification of CD11b+ and Sialoadhesin (Sn)+ cells was performed as described before [1] in the rostral region. CD4+ and CD8+ T-cells were quantified in total longitudinal optic nerve sections, using a Zeiss Axiophot2 microscope and measurement tools as described above.
###end p 28
###begin title 29
Detection of cytokines by ELISA and ELISPOT
###end title 29
###begin p 30
###xml 4 5 4 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
1x106/ml splenocytes were cultured unstimulated or stimulated with ConA (2 microg/ml, Sigma, Schnelldorf, Germany) or CD3/CD28 coated microspheres (Dynal, Invitrogen, Karlsruhe, Germany). After 48 hours, supernatant was harvested and ELISA for IFN-gamma, IL-2 or IL-10 (R&D Systems, Minneapolis, MN, USA) was performed according to the manufacturers instructions.
###end p 30
###begin p 31
###xml 89 90 85 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 114 115 110 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 362 365 358 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Leder1">[4]</xref>
Assessment of interferon-gamma (IFN-gamma) producing cells was performed by ELISPOT. 1x104 CNS lymphocytes or 1x105 splenocytes per well were incubated for 24 hours, unstimulated or stimulated with PMA (20 ng/ml)/Ionomycin (500 ng/ml, both Sigma), or a mixture of class one PLP, MOG and MBP peptides (Genscript Corp, Piscataway, NJ, USA) as previously described [4]. ELISPOT assay was performed according to the manufacturers instructions (BD Pharmingen). Spots were quantified by CTL Europe (Aalen, Germany) using ImmunoSpot 4.0.17.
###end p 31
###begin title 32
CDR3 Spectratyping
###end title 32
###begin p 33
###xml 61 64 61 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Leder1">[4]</xref>
###xml 66 70 66 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Pannetier1">[21]</xref>
The CDR3 spectratyping was performed as described previously [4], [21] using an ABI Prism 3130 capillary sequencer (Applied Biosystems) to determine length and distribution, using a module for fragment-analysis. As an internal length standard, 500-ROX (Applied Biosystems) was used.
###end p 33
###begin title 34
Statistical analysis
###end title 34
###begin p 35
Quantified profiles were tested with two-tailed student's t-test, scores were analyzed by the nonparametric Mann-Whitney-U test and Kruskal-Wallis test.
###end p 35
###begin title 36
Results
###end title 36
###begin p 37
The role of PD-1, a co-inhibitory molecule critical for immune homeostasis and tolerance, was tested in a model of CNS-myelinopathy associated with secondary, low grade inflammation of high pathological relevance.
###end p 37
###begin title 38
Numbers of CNS immune cells are significantly elevated in PLPtg/PD-1-/- double mutants
###end title 38
###begin p 39
###xml 165 168 165 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Ip1">[1]</xref>
###xml 170 173 170 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Ip2">[3]</xref>
###xml 460 463 460 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Ip1">[1]</xref>
###xml 465 469 465 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Murer1">[18]</xref>
###xml 414 418 <span type="species:ncbi:10090">mice</span>
###xml 445 449 <span type="species:ncbi:10090">mice</span>
To obtain myelin mutants with inactivated PD-1 function, two strategies have been chosen. First, double mutants have been created in analogy to previous experiments [1], [3] by crossbreeding the corresponding single mutants. This strategy has the advantage that all cells of the organism lack PD-1. Complementarily, bone marrow chimeric mutants have been generated using either irradiated or RAG-1-deficient PLPtg mice as recipients and PD-1-/- mice as donors [1], [18]. The latter strategy has the advantage that unexpected side effects or influences of the systemic PD-1-inactivation (e.g. influences of PD-1 deficiency on thymic maturation or neonatal tolerance) can be circumvented.
###end p 39
###begin p 40
###xml 333 336 333 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Ip1">[1]</xref>
###xml 338 341 338 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Ip2">[3]</xref>
###xml 343 347 343 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Ip3">[22]</xref>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
PLPtg/PD-1-/- double mutants and their respective controls (wt, PD-1-/- and PLPtg mice), were examined at the age of 2, 6 and 12 months (n = 3-7). To quantify immune cells in the CNS, we focussed on longitudinal sections of the optic nerve, an already established read out technique for the scoring of inflammation in PLP mutant CNS [1], [3], [22].
###end p 40
###begin p 41
###xml 559 568 559 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004405-g001">Figure 1A</xref>
###xml 1063 1075 1063 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004405-g001">Figure 1B, C</xref>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
###xml 240 244 <span type="species:ncbi:10090">mice</span>
###xml 363 367 <span type="species:ncbi:10090">mice</span>
###xml 493 497 <span type="species:ncbi:10090">mice</span>
###xml 553 557 <span type="species:ncbi:10090">mice</span>
###xml 588 592 <span type="species:ncbi:10090">mice</span>
###xml 750 754 <span type="species:ncbi:10090">mice</span>
###xml 830 834 <span type="species:ncbi:10090">mice</span>
###xml 882 886 <span type="species:ncbi:10090">mice</span>
###xml 1057 1061 <span type="species:ncbi:10090">mice</span>
At the age of two months, there was no significant difference between wt, PD-1-/-, PLPtg and PLPtg/PD-1-/- mice. At 6 months, however, there was a slight elevation of CD8+ T- cells in the optic nerve of PLPtg mice in comparison to wildtype mice, consistent with our previous observations. PD-1-/- also showed a mild elevation, whereas PLPtg/PD-1-/- double mutant mice exhibited a robust upregulation of CD8+ T-cells in optic nerve sections (approximately 35-fold increase compared to wildtype mice and a more than 8 fold increase in comparison to PLPtg mice, Figure 1A). In 12 months old mice, the general pattern of CD8+ lymphocyte numbers in optic nerves was similar in the different genotypes, but proportions had shifted a little: wt and PD-1-/- mice were now at similar levels (with no marked increase of profiles in PD-1-/- mice compared to the 6 months old group), and PLPtg mice displayed significantly more CD8+ profiles than the former two genotypes. Strikingly, these CD8+ T-lymphocytes were again clearly outnumbered by those from PLPtg/PD-1-/- mice (Figure 1B, C).
###end p 41
###begin title 42
###xml 192 196 <span type="species:ncbi:10090">mice</span>
###xml 239 243 <span type="species:ncbi:10090">mice</span>
Quantification and immunohistochemical detection of CD8+ and CD4+ lymphocytes and CD11b+ macrophage-like cells in longitudinal sections of optic nerves of wt, PD-1-/-, PLPtg and PLPtg/PD-1-/- mice and of CD8+ cells in bone marrow chimeric mice
###end title 42
###begin p 43
###xml 90 94 <span type="species:ncbi:10090">mice</span>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 371 375 <span type="species:ncbi:10090">mice</span>
###xml 591 595 <span type="species:ncbi:10090">mice</span>
- A, B. Quantification of CD8+ lymphocytes in 6 (A: n = 3) and 12 (B: n = 3-7) months old mice of different genotypes. C. Immunohistochemical detection of CD8+ lymphocytes in the optic nerve of 12 months old mice of different myelin and immunological genotypes. Arrows indicate positively labelled CD8+ lymphocytes. D. Quantification of CD4+ lymphocytes in 12 months old mice (n = 3-7). Note that in the myelin mutants, both CD8+ and the generally scarce CD4+ lymphocytes are substantially increased in the absence of PD-1. E. Quantification of CD11b+ macrophage-like cells in 12 months old mice (n = 3-6). Note that the number CD11b+ cells does not differ significantly in PLPtg/PD-1+/+ and PLPtg/PD-1-/- double mutants. Similar results are obtained in irradiated and non-irradiated (RAG-1-/-) PLPtg bone-marrow recipients. The rather small increase of CD11b+ cells is not surprising, since the molecule in focus (PD-1) is a component of predominantly T-lymphocytes rather than of macrophages/microglial cells. F. Quantification of CD8+ cells in the CNS of 10 months old PLPtg bone marrow chimeras (BMCs) which were transplanted with either wt or PD-1-/- bone marrow (n = 8-9). Note that also in bone marrow chimeras, CD8+ T-lymphocytes are substantially elevated in the CNS of PLPtg mutants in the absence of PD-1. Error bars represent standard deviations. * p- value<0.05, ** p - value</=0.01. Scale Bar: 50 microm.
###end p 43
###begin p 44
###xml 70 73 70 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Ip1">[1]</xref>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
CD4+ T-lymphocytes are rarely present in the CNS of PLPtg and wt mice [1]. At the age of two months, no differences were detectable in all investigated groups.
###end p 44
###begin p 45
###xml 204 213 204 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004405-g001">Figure 1D</xref>
###xml 138 142 <span type="species:ncbi:10090">mice</span>
At the age of 6 months a significant elevation of CD4+ lymphocytes was already visible in PLPtg/PD-1-/- compared to wt, PD-1-/- and PLPtg mice and there was no marked increase until the age of 12 months (Figure 1D). Similar changes in T-lymphocyte numbers were detected in the spinal cord (data not shown).
###end p 45
###begin p 46
###xml 496 505 496 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004405-g001">Figure 1E</xref>
###xml 233 237 <span type="species:ncbi:10090">mice</span>
###xml 318 322 <span type="species:ncbi:10090">mice</span>
###xml 383 387 <span type="species:ncbi:10090">mice</span>
###xml 453 457 <span type="species:ncbi:10090">mice</span>
Furthermore, we investigated the number of CD11b+ macrophage-like cells in the optic nerve. We did not detect significant differences at the age of 2 or 6 months, although a trend of increased numbers was already detectable in PLPtg mice and PLPtg/PD-1-/- double mutants at 6 months (data not shown). In 12 months old mice, however, a difference was detectable. While wt and PD-1-/- mice showed a common low level of cells, both PLPtg and PLPtg/PD-1-/- mice had elevated numbers of CD11b+ cells (Figure 1E).
###end p 46
###begin p 47
###xml 125 129 <span type="species:ncbi:10090">mice</span>
###xml 211 215 <span type="species:ncbi:10090">mice</span>
###xml 345 349 <span type="species:ncbi:10090">mice</span>
We additionally investigated the number of Sialoadhesin (Sn) expressing macrophage like cells in 12 months old PLPtg/PD-1-/- mice and detected a very low amount of positive profiles in both wildtype and PD-1-/- mice. In PLPtg, a more than ten-fold increase was detectable, but there was no significant difference between PLPtg and PLPtg/PD-1-/- mice (data not shown).
###end p 47
###begin title 48
Numbers of immune cells are significantly elevated in PLPtg PD-1-/- transplanted bone marrow chimeras (BMCs)
###end title 48
###begin p 49
###xml 58 62 <span type="species:ncbi:10090">mice</span>
###xml 84 88 <span type="species:ncbi:10090">mice</span>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
###xml 187 191 <span type="species:ncbi:10090">mice</span>
###xml 217 221 <span type="species:ncbi:10090">mice</span>
Another strategy to investigate the role of PD-1 in PLPtg mice was to examine PLPtg mice which were transplanted with bone marrow from either PD-1-/- mice (PLPtg BMC PD-1-/-) or wildtype mice (PLPtg BMC wt). Wildtype mice which were transplanted with either wildtype or PD-1-/- bone marrow served as controls. These animals never displayed myelin pathology or CNS inflammation in any experiment.
###end p 49
###begin p 50
###xml 255 264 255 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004405-g001">Figure 1F</xref>
###xml 25 29 <span type="species:ncbi:10090">mice</span>
###xml 249 253 <span type="species:ncbi:10090">mice</span>
###xml 506 510 <span type="species:ncbi:10090">mice</span>
The bone marrow chimeric mice faithfully reflected the findings described for the double mutants. For example, both irradiated and PLPtg/RAG-1-/- recipients showed a robust upregulation of CD8+ lymphocytes, when bone marrow was derived from PD-1-/- mice (Figure 1F). Similar observations were made for the low but significantly elevated amount of CD4+ cells (data not shown). Increased elevation of CD8+ and CD4+ cells in the absence of PD-1 was significant both in irradiated and in RAG-1-deficient PLPtg mice.
###end p 50
###begin p 51
###xml 182 186 <span type="species:ncbi:10090">mice</span>
###xml 229 233 <span type="species:ncbi:10090">mice</span>
###xml 297 301 <span type="species:ncbi:10090">mice</span>
Analysis of CD11b+ macrophage like cells depicted a small, significant increase in PLPtg PD-1-/- transplanted chimeras compared to recipients that received bone marrow from wildtype mice (data not shown). In the irradiated PLPtg mice statistical significance was reached, while the PLPtg/RAG-1-/- mice showed a trend into the same direction but did not reach the level of significance (p = 0.06).
###end p 51
###begin title 52
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Pathological features are enhanced in PLPtg/PD-1-/- double mutated mice
###end title 52
###begin p 53
###xml 312 321 312 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004405-g002">Figure 2A</xref>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
###xml 130 134 <span type="species:ncbi:10090">mice</span>
###xml 223 227 <span type="species:ncbi:10090">mice</span>
MBP immunohistochemistry revealed that, while wildtype and PD-1-/- mice always showed a homogeneous distribution of myelin, PLPtg mice displayed a more patchy and inhomogeneous MBP staining. Compared to that, PLPtg/PD-1-/- mice showed an even less homogeneous MBP distribution, reflecting extensive myelin loss (Figure 2A).
###end p 53
###begin title 54
###xml 83 87 <span type="species:ncbi:10090">mice</span>
Quantification of pathological features in various myelin and PD-1 mutants and BMC mice
###end title 54
###begin p 55
###xml 112 116 <span type="species:ncbi:10090">mice</span>
###xml 170 174 <span type="species:ncbi:10090">mice</span>
###xml 279 283 <span type="species:ncbi:10090">mice</span>
###xml 475 480 <span type="species:ncbi:10090">mouse</span>
###xml 746 750 <span type="species:ncbi:10090">mice</span>
###xml 853 857 <span type="species:ncbi:10090">mice</span>
A. MBP immunohistochemistry of optic nerve cross sections of 12 months old wt, PD-1-/-, PLPtg and PLPtg/PD-1-/- mice. Note homogeneous MBP distribution in wt and PD-1-/- mice compared to more disrupted myelin (inhomogeneous labeling) in PLPtg and, more pronounced, PLPtg/PD-1-/- mice. B.-D. MBP immunohistochemistry (B), immunohistochemical detection of CD8+ cells (C) and hematoxylin eosin staining (D) in a plaque like demyelinating lesion in a 12 months old PLPtg/PD-1-/- mouse. Note sharply confined lesion (B) with accumulated T-cells (C) and other, probably inflammatory, cell nuclei (D). E. Quantification of demyelination by measuring MBP-negative areas. PD-1-deficient myelin mutants (PLPtg/PD-1-/-) show more severe MBP loss than PLPtg mice expressing PD-1 (PLPtg; n = 4-6). F.,G. Semithin optic nerve sections sections of 10 months old PLPtg mice which were transplanted with wt (F) or PD-1-/- (G) bone marrow. Arrows indicate periaxonal vacuoles which are more numerous in PD-1-/- BMCs. H. Quantification of vacuoles >6 microm in bone marrow chimeras. PD-1-deficiency leads to the most robust histopathological alterations in the myelin mutants and the most seriously affected mutants belong to the PD-1-deficient group (n = 3-5). * p- value<0.05, ** p - value</=0.01. Scale bars: 50 microm.
###end p 55
###begin p 56
###xml 189 198 189 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004405-g002">Figure 2B</xref>
###xml 270 279 270 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004405-g002">Figure 2C</xref>
###xml 347 356 347 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004405-g002">Figure 2D</xref>
Interestingly, in one PLPtg/PD-1-/- optic nerve we observed an extended and sharply confined area of MBP-loss, reminiscent of a demyelinated lesion common to active or inactive MS plaques (Figure 2B). This lesion was associated with an accumulation of CD8+ lymphocytes (Figure 2C) and hematoxylin-stained cells of probably inflammatory character (Figure 2D).
###end p 56
###begin p 57
###xml 331 340 331 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004405-g002">Figure 2E</xref>
###xml 190 194 <span type="species:ncbi:10090">mice</span>
###xml 267 271 <span type="species:ncbi:10090">mice</span>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
###xml 464 468 <span type="species:ncbi:10090">mice</span>
###xml 513 517 <span type="species:ncbi:10090">mice</span>
###xml 569 573 <span type="species:ncbi:10090">mice</span>
###xml 770 777 <span type="species:ncbi:9606">persons</span>
###xml 924 928 <span type="species:ncbi:10090">mice</span>
###xml 1055 1059 <span type="species:ncbi:10090">mice</span>
###xml 1091 1095 <span type="species:ncbi:10090">mice</span>
To quantify the demyelinating phenotype of the different mutants, MBP-negative areas of optic nerve cross sections were determined as measure for demyelination. Neither wildtype nor PD-1-/- mice showed any MBP-negative areas, while demyelination was present in PLPtg mice and further significantly increased in PLPtg/PD-1-/- mice (Figure 2E). Additionally, myelin integrity-related MBP distribution was analysed by semi-quantitative scoring. Again, wt and PD-1-/- mice showed healthy myelin (score 1) while PLPtg mice had an average score of 3+/-0.81 and PLPtg/PD-1-/- mice showed a higher score (3.83+/-0.75). PD-1-deficiency leads to the highest MBP loss in the myelin mutants and the most seriously affected mutants belong to the PD-1-deficient group. Generally, the persons investigating the histopathological features (A. K., R. M.) were not aware of the respective genotypes. Similar to these results in double mutant mice, 10 months old PLPtg BMCs reconstituted with PD-1-/- bone marrow showed a more disrupted state of MBP distribution than PLPtg mice transplanted with BMCs from wt mice (data not shown).
###end p 57
###begin p 58
###xml 127 130 127 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Ip1">[1]</xref>
###xml 132 135 132 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Ip2">[3]</xref>
###xml 264 268 <span type="species:ncbi:10090">mice</span>
###xml 373 377 <span type="species:ncbi:10090">mice</span>
We also investigated periaxonal vacuoles in semithin cross sections of the optic nerve as another reliable pathological marker [1], [3] (age of 12 months in double mutants, age of 10 months in bone marrow chimeras). PLPtg/PD-1-/- double mutants, compared to PLPtg mice, showed a clear trend of increased vacuole numbers (13.3+/-7.9 versus 7.95+/-3.6), while wt and PD-1-/- mice never displayed any vacuoles (data not shown).
###end p 58
###begin p 59
###xml 104 119 104 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004405-g002">Figure 2F, G, H</xref>
###xml 154 158 <span type="species:ncbi:10090">mice</span>
PLPtg BMCs transplanted with PD-1-/- bone marrow showed a highly significant increase of axonal damage (Figure 2F, G, H). In the optic nerves of wildtype mice, we never detected any vacuoles, regardless what kind of bone marrow had been transplanted.
###end p 59
###begin title 60
###xml 87 91 <span type="species:ncbi:10090">mice</span>
T-cell CDR3 spectratype analysis: robust clonal expansions in the CNS of PLPtg/PD-1-/- mice
###end title 60
###begin p 61
###xml 227 230 218 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Leder1">[4]</xref>
###xml 432 435 420 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Leder1">[4]</xref>
###xml 184 188 <span type="species:ncbi:10090">mice</span>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
Evidence for monoclonal T-cell expansions as revealed by single Vbeta-Jbeta peaks in the corresponding PCR-diagrams could be detected (one Vbeta peak per animal) in 12-month-old PLPtg mice corroborating these previous findings [4]. Corresponding expansions could not be detected in spectratyping analyses from lymphocytes of wild type mice. Spleens of the same animals displayed the expected Gaussian distribution of Vbeta profiles [4].
###end p 61
###begin p 62
###xml 74 82 71 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004405-g003">Figure 3</xref>
###xml 182 190 176 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004405-g003">Figure 3</xref>
###xml 28 32 <span type="species:ncbi:10090">mice</span>
###xml 422 426 <span type="species:ncbi:10090">mice</span>
CDR3 spectratype in PD-1-/- mice (n = 7) showed more than one Vbeta peak (Figure 3). Similarly, multiple Vbeta peaks were visible in the CNS of PLPtg/PD-1-/- double mutants (n = 3) (Figure 3), as well as in 10 months old PLPtg/PD-1-/- BMCs (n = 5). The clonal expansions occurred widely distributed over different Vbeta and Jbeta regions, although some domains seemed to be prone for clonal expansions in different mutant mice. Notably, approximately 30% of the individual clonal expansions were detected in both spleen and brain, 70% of the expansions were exclusively present in CNS tissue.
###end p 62
###begin title 63
Spectratyping of CNS derived lymphocytes
###end title 63
###begin p 64
###xml 74 77 74 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Leder1">[4]</xref>
###xml 122 126 <span type="species:ncbi:10090">mice</span>
###xml 599 603 <span type="species:ncbi:10090">mice</span>
###xml 649 653 <span type="species:ncbi:10090">mice</span>
- Lymphocytes from the CNS of 12 months old PLPtg (n = 7, as adopted from [4], PD-1-/- (n = 7), and PLPtg/PD-1-/- (n = 4) mice were analysed for disturbances in the T-cell receptor repertoire by spectratyping. Clonal expansions (visible as single peaks in the fragment analysis) are shown as colored dots (different colors indicate individual animals). The expanded T-cells are characterized by their Vbeta- and Jbeta-chains. The clonal expansions occurred widely distributed over different Vbeta and Jbeta regions, although some domains seemed to be prone for clonal expansions in different mutant mice. Note that different numbers of experimental mice contribute to the different numbers of dots.
###end p 64
###begin p 65
###xml 452 460 440 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004405.s003">Table S1</xref>
###xml 296 301 <span type="species:ncbi:10090">mouse</span>
###xml 446 450 <span type="species:ncbi:10090">mice</span>
We then sequenced some clones to 1) demonstrate that the specific PCR fragment represents one TCR (a readable sequence proves the existence of an expansion), and 2) to detect similarities between the CDR3s of different clonal expansions. For example, by analysing the sequences of 2 individuals (mouse A and B) we identified two expansions with the same VbetaJbeta combination and one expansion with a different VbetaJbeta combination in the two mice (Table S1). While those D segments with flanking N sequences ( = NDN) amino acids, responsible for connecting with the MHC-bound antigen, show some similarities, the lengths of the CDR3 are not identical, showing that these clones are not specific for the exact same antigen.
###end p 65
###begin title 66
###xml 58 63 <span type="species:ncbi:10090">mouse</span>
Peripheral immune parameters do not differ between mutant mouse strains
###end title 66
###begin p 67
###xml 68 73 <span type="species:ncbi:10090">mouse</span>
###xml 197 201 <span type="species:ncbi:10090">mice</span>
In order to exclude that peripheral immune parameters in the mutant mouse strains could account for the different numbers of immune cells and the aggravated pathological features in double mutated mice, we analyzed (i) phagocytic capability of macrophages, (ii) inducibility and rate of stimulation-induced apoptosis of splenocytes, (iii) immune subset distribution (CD4+, CD8+, CD11b+, B220), and (iv) levels of stimulation induced IL-2 production between the different groups (wt, PD-1-/-, PLPtg, PLPtg/PD-1-/-).
###end p 67
###begin p 68
###xml 293 304 293 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004405.s002">Material S1</xref>
###xml 306 315 306 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0004405.s001">Figure S1</xref>
The phagocytic capacity of peritoneal macrophages was similar in all genotypes. Furthermore, investigation of splenocytes showed no significant differences between the different genotypes used in this study in regard of inducibility of apoptosis, cell subsets and production of cytokines (see Material S1, Figure S1).
###end p 68
###begin title 69
CNS T-cells are prone to IFN-gamma secretion in the absence of PD-1
###end title 69
###begin p 70
###xml 67 72 <span type="species:ncbi:10090">mouse</span>
Polyclonal immune responses in the periphery do not differ between mouse mutants. We therefore tested whether CNS cells show altered production of inflammatory cytokines upon stimulation. IFN-gamma secretion of CNS-derived T-lymphocytes was measured after addition of PMA/ionomycin or upon antigenic stimulation.
###end p 70
###begin p 71
###xml 216 225 212 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004405-g004">Figure 4A</xref>
###xml 301 310 297 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0004405-g004">Figure 4B</xref>
###xml 388 391 384 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Leder1">[4]</xref>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
Interestingly, CNS lymphocytes of PD-1-/- and PLPtg/PD-1-/- mice showed strong IFN-gamma secretion upon PMA/ionomycin challenge, while CNS T-cells from PLPtg mice or wt showed only minimal or no cytokine production (Figure 4A). Of note, such differences have not been observed in T-cells from spleen (Figure 4B). Antigenic stimulation with a number of MHC class I related myelin peptides [4] did not lead to IFN-gamma production of CNS T-cells under any condition (ELISPOT, data not shown).
###end p 71
###begin title 72
IFN-gamma ELISPOT assay on spleen and brain derived lymphocytes
###end title 72
###begin p 73
###xml 156 160 <span type="species:ncbi:10090">mice</span>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
###xml 270 274 <span type="species:ncbi:10090">mice</span>
- IFN-gamma ELISPOT assay after stimulation with PMA/ionomycin on CNS derived lymphocytes (A) and splenocytes (B) from wt, PD-1-/-, PLPtg and PLPtg/PD-1-/- mice. Note elevated spot numbers in CNS T-lymphocytes taken from PLPtg/PD-1-/- mice in comparison to wt and PLPtg mice, reflecting a higher susceptibility to activation. Error bars represent standard deviations. * p - value<0.05, ** p - value</=0.01
###end p 73
###begin title 74
Discussion
###end title 74
###begin p 75
###xml 259 262 259 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Ip1">[1]</xref>
###xml 264 267 264 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Ip2">[3]</xref>
###xml 269 272 269 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Leder1">[4]</xref>
###xml 274 278 274 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Ip4">[23]</xref>
###xml 280 284 280 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Kassmann1">[24]</xref>
###xml 286 290 286 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Grundtner1">[25]</xref>
###xml 499 502 499 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Ip1">[1]</xref>
###xml 585 588 585 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Leder1">[4]</xref>
###xml 590 594 590 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Grundtner1">[25]</xref>
###xml 1238 1242 1238 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Okazaki3">[26]</xref>
###xml 1308 1312 1308 1312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Sharpe1">[27]</xref>
###xml 1453 1457 1453 1457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Kroner1">[12]</xref>
###xml 1459 1463 1459 1463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Prokunina1">[28]</xref>
###xml 17 22 <span type="species:ncbi:9606">human</span>
###xml 127 131 <span type="species:ncbi:10090">mice</span>
###xml 1079 1083 <span type="species:ncbi:10090">mice</span>
###xml 1098 1104 <span type="species:ncbi:9606">humans</span>
###xml 1415 1420 <span type="species:ncbi:9606">human</span>
Recent data from human studies in distinct leukodystrophies and some forms of MS together with investigations in myelin mutant mice indicate that a primary glial injury can be causative for neuroinflammation of substantial pathological and clinical relevance [1], [3], [4], [23], [24], [25]. Further characterization of "secondary" inflammatory responses in a model of PLP overexpression identified CD8+ T-lymphocytes of effector cell phenotype as crucial mediators of demyelination and axon damage [1]. The finding that CD8+ T-cells in the CNS of myelin mutants are clonally expanded [4], [25] further supports a pathogenetic concept that primary myelin damage in the CNS can be associated with secondary reactivity of the adaptive immune system against a still unknown antigen(s). Another key question in this scenario is which factors control tissue homeostasis of immune cells. We therefore investigated the impact of immune-regulatory mechanisms on the adaptive immunity in PLP overexpressing mutants focussing on the role of the co-inhibitory molecule PD-1. Recent data in mice as well as in humans demonstrate that PD-1 is substantially involved in the control of T-cell homeostasis under physiological and pathological conditions [26] by preventing uncontrolled proliferation of autoreactive T-cells [27]. In accordance with these functional data, certain polymorphisms in the PD-1 gene are associated with human autoimmune disease including MS [12], [28].
###end p 75
###begin p 76
###xml 143 147 <span type="species:ncbi:10090">mice</span>
Our present experiments show that PD-1 plays a major role in modulating numbers of CD8+ cells in the demyelinating model of PLP overexpressing mice.
###end p 76
###begin p 77
###xml 57 61 <span type="species:ncbi:10090">mice</span>
###xml 285 289 <span type="species:ncbi:10090">mice</span>
The most relevant finding of our study was that in PLPtg mice the histopathological phenotype was much more severe when PD-1 was absent. Interestingly, not only CNS damage was more pronounced per individual, but most severely affected individuals always belonged to the group of PLPtg mice in combination to functional disruption of PD-1.
###end p 77
###begin p 78
###xml 359 363 359 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Nishimura1">[16]</xref>
###xml 1152 1155 1152 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Leder1">[4]</xref>
###xml 1644 1648 1641 1645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Sheppard1">[29]</xref>
###xml 191 195 <span type="species:ncbi:10090">mice</span>
###xml 284 288 <span type="species:ncbi:10090">mice</span>
###xml 710 714 <span type="species:ncbi:10090">mice</span>
###xml 853 857 <span type="species:ncbi:10090">mice</span>
###xml 961 965 <span type="species:ncbi:10090">mice</span>
###xml 1052 1056 <span type="species:ncbi:10090">mice</span>
###xml 1533 1537 <span type="species:ncbi:10090">mice</span>
###xml 1829 1833 <span type="species:ncbi:10090">mice</span>
How does ablation of the PD-1 pathway affect CNS pathology? PD-1-deficiency alone only transiently affected the number of CD8+ cells found in the CNS and, more importantly, the corresponding mice showed normal histological features in the CNS. While it has been reported that PD-1-/- mice on a C57/Bl6 background show lupus-like glomerulonephritis when aging [16] we did not observe any obvious organ pathology, urinal glucose or protein content (not shown) or spontaneous autoreactions associated with loss of PD-1. Furthermore, the peripheral immune "status" was not changed in the tested groups (wt, PD-1-/-, PLPtg, PLPtg/PD-1-/-). However, we found clonal expansions of T-cells in the periphery in PD-1-/- mice using CDR3 spectratyping analysis. While numerically not elevated in the CNS at 12 months, the PD-1-deficient CD8+ cells of PLPwt/PD-1-/- mice showed multiple clonal T-cell expansions, as opposed to PD-1-expressing CD8+ cells of normal wild type mice which do not show any repertoire perturbations. The corresponding CD8+ cells of PLPtg mice display their characteristic mono- or oligoclonal expansion in the CNS as previously described [4]. The combination of the PLP transgene with PD-1 deficiency led to significantly higher numbers of T-cells within the CNS. Moreover, CD8+ T-lymphocytes of PD-1 mutants are aberrant with regard of their strong numerical increase and prominent clonal expansions. This suggests that PD-1 prevents a large number of possible clonal expansions of a variety of T-cell clones in PLPtg mice. PD-1 signalling is known to attenuate signals of the T-cell receptor such as PKCtheta and ZAP-70/CD3zeta [29]. This could also be the explanation that only CNS T-cells deficient of PD-1 show markedly enhanced INF-gamma secretion after stimulation, whereas CNS CD8+ cells from genuine PLPtg mice show no relevant production of this proinflammatory cytokine. These findings suggest that although prominently expanded and highly susceptible to become activated, PD-1-deficient T-lymphocytes appear to be pathologically "silent" in a healthy environment.
###end p 78
###begin p 79
###xml 159 163 159 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Magnus1">[20]</xref>
###xml 165 169 165 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Sharpe1">[27]</xref>
###xml 171 175 171 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Carter1">[30]</xref>
###xml 177 181 177 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Fife1">[31]</xref>
###xml 183 187 183 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Keir1">[32]</xref>
###xml 287 291 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-MartinOrozco1">[33]</xref>
###xml 431 435 431 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Magnus1">[20]</xref>
###xml 437 441 437 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Salama1">[34]</xref>
###xml 586 590 586 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Ortler1">[35]</xref>
###xml 705 709 <span type="species:ncbi:10090">mice</span>
Due to its inhibitory properties the cognate ligand PD-L1 has been proposed to contribute to maintaining peripheral tolerance and limiting inflammatory damage [20], [27], [30], [31], [32]. Parenchymal PD-L1 contributes to the limitation of insulinitis and the resolution of inflammation [33]. We and others recently reported that PD-L1 is expressed and upregulated on CNS cells (e.g. microglia cells) under inflammatory conditions [20], [34], restricts parenchymal neuroantigen-specific T-cell responses and confines inflammatory CNS damage in experimental autoimmune encephalomyelitis [35]. One therefore might assume that PD-L1 - PD-1 interactions counteract T-cell mediated pathology observed in PLPtg mice by limiting clonal expansion and cytokine release of detrimentally self-reactive low avidity clones.
###end p 79
###begin p 80
###xml 279 282 279 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Ip1">[1]</xref>
###xml 445 448 445 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Ip2">[3]</xref>
###xml 662 665 662 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0004405-Leder1">[4]</xref>
A synoptic view summarizing our recent and previous observations may be as follows: overexpression of PLP may induce intracellular stress that causes several immune-relevant glial reactions, such as expression of cytokines and upregulation of MHC-I molecules on oligodendrocytes [1] and Sn on the surface of macrophage-like cells. It is of note that the latter reaction is an important prerequisite for CD8+ cell activation in the present model [3]. Furthermore, supraphysiological concentrations of myelin antigens associated with PLP-overexpression could promote reactivity of low-avidity T-cell clones that survived clonal deletion or ignorance in the thymus [4]. CNS-derived, but not spleen-derived CD8+ cells show mono- or oligoclonal expansions, further suggesting CNS-restricted specificity against yet unidentified CNS-antigens. PD-1 is critically involved in these processes: in the presence of PD-1 on CNS CD8+ cells, activation and proliferation is limited, whereas absence of PD-1 leads to substantial increase of CD8+ cells, a higher propensity to secrete proinflammatory cytokines, multiple clonal expansions and an aggravation of neural damage.
###end p 80
###begin p 81
Taken together, our study demonstrates the important role of a co-inhibitory molecule, PD-1, in modulating glial-injury-related immune responses in the CNS. This impressively reflects the high and obviously wide-range relevance of immunmodulatory mechanisms under various pathological conditions and should be particularly considered when seeking for mechanisms leading to the high clinical variability of polygenic or even monogenic disorders of the nervous system.
###end p 81
###begin title 82
Supporting Information
###end title 82
###begin p 83
Exclusion of differences in the peripheral immune systems of wt, PD-1-/-, PLPtg and PLPtg/PD-1-/- double mutants. Peritoneal macrophages were incubated with fluorescent latex beads and the percentage of macrophages which ingested beads was found similar in all genotypes (A). Differences in the apoptosis rate were excluded by flow cytometry of annexin V and PI positive splenocytes under highly stimulatory conditions (B). Analysis of immune cell subsets (CD4+, CD8+, CD11b+ and B220+ cells) showed similar distribution in splenocytes of all investigated genotypes (C). Exclusion of deviations in peripheral proinflammatory activation using unstimulated and stimulated splenocytes from different genotypes, by examining IL-2 in the corresponding supernatants by ELISA (D). Error bars represent standard deviations.
###end p 83
###begin p 84
(0.39 MB TIF)
###end p 84
###begin p 85
Click here for additional data file.
###end p 85
###begin p 86
Material and Methods S1
###end p 86
###begin p 87
(0.03 MB DOC)
###end p 87
###begin p 88
Click here for additional data file.
###end p 88
###begin p 89
###xml 108 112 <span type="species:ncbi:10090">mice</span>
###xml 183 188 <span type="species:ncbi:10090">mouse</span>
CDR3 sequences. Sequencing analysis of two clones with identical VbetaJbeta combinations from PLPtg/PD-1-/- mice A and B and of one clone with a different VbetaJbeta combination from mouse A. Note identical TCRVbeta and TCRJbeta regions surrounding the CDR3 region, which not only differs in aminoacids but also, more importantly, in length, thus indicating recognition of different antigens.
###end p 89
###begin p 90
(0.03 MB DOC)
###end p 90
###begin p 91
Click here for additional data file.
###end p 91
###begin p 92
The authors are grateful to Heinrich Blayzca, Carolin Kiesel, Barbara Michel and Nadine Weckesser for expert technical assistance, Helga Brunner and Karl Heinz Aulenbach for most skilful animal care and Klaus V. Toyka and Christian Blank for support and valuable discussions, respectively.
###end p 92
###begin title 93
References
###end title 93
###begin article-title 94
###xml 74 78 <span type="species:ncbi:10090">mice</span>
Immune cells contribute to myelin degeneration and axonopathic changes in mice overexpressing proteolipid protein in oligodendrocytes.
###end article-title 94
###begin article-title 95
Siglecs in innate immunity.
###end article-title 95
###begin article-title 96
###xml 113 117 <span type="species:ncbi:10090">mice</span>
Sialoadhesin deficiency ameliorates myelin degeneration and axonopathic changes in the CNS of PLP overexpressing mice.
###end article-title 96
###begin article-title 97
###xml 80 84 <span type="species:ncbi:10090">mice</span>
Clonal expansions of pathogenic CD8+ effector cells in the CNS of myelin mutant mice.
###end article-title 97
###begin article-title 98
Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.
###end article-title 98
###begin article-title 99
Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion.
###end article-title 99
###begin article-title 100
Primary progressive multiple sclerosis as a phenotype of a PLP1 gene mutation.
###end article-title 100
###begin article-title 101
###xml 44 49 <span type="species:ncbi:9606">child</span>
Steroid-responsive neurologic relapses in a child with a proteolipid protein-1 mutation.
###end article-title 101
###begin article-title 102
###xml 56 61 <span type="species:ncbi:9606">human</span>
Applying a new generation of genetic maps to understand human inflammatory disease.
###end article-title 102
###begin article-title 103
New regulatory co-receptors: inducible co-stimulator and PD-1.
###end article-title 103
###begin article-title 104
PD-1 and PD-1 ligands: from discovery to clinical application.
###end article-title 104
###begin article-title 105
A PD-1 polymorphism is associated with disease progression in multiple sclerosis.
###end article-title 105
###begin article-title 106
###xml 21 26 <span type="species:ncbi:10090">mouse</span>
Immune deficiency in mouse models for inherited peripheral neuropathies leads to improved myelin maintenance.
###end article-title 106
###begin article-title 107
###xml 40 55 <span type="species:ncbi:10090">transgenic mice</span>
Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage.
###end article-title 107
###begin article-title 108
Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor.
###end article-title 108
###begin article-title 109
###xml 74 78 <span type="species:ncbi:10090">mice</span>
Preserved myelin integrity and reduced axonopathy in connexin32-deficient mice lacking the recombination activating gene-1.
###end article-title 109
###begin article-title 110
###xml 36 40 <span type="species:ncbi:10090">mice</span>
Bone marrow transfer from wild type mice reverts the beneficial effect of genetically-mediated immune deficiency in myelin mutants.
###end article-title 110
###begin article-title 111
Rapid response of identified resident endoneurial macrophages to nerve injury.
###end article-title 111
###begin article-title 112
Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNS.
###end article-title 112
###begin article-title 113
T-cell repertoire diversity and clonal expansions in normal and clinical samples.
###end article-title 113
###begin article-title 114
###xml 72 76 <span type="species:ncbi:10090">mice</span>
Origin of CD11b+ macrophage-like cells in the CNS of PLP-overexpressing mice: low influx of haematogenous macrophages and unchanged blood-brain-barrier in the optic nerve.
###end article-title 114
###begin article-title 115
Role of immune cells in animal models for inherited peripheral neuropathies.
###end article-title 115
###begin article-title 116
Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes.
###end article-title 116
###begin article-title 117
Transition from enhanced T cell infiltration to inflammation in the myelin-degenerative central nervous system.
###end article-title 117
###begin article-title 118
The PD-1-PD-L pathway in immunological tolerance.
###end article-title 118
###begin article-title 119
The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection.
###end article-title 119
###begin article-title 120
###xml 104 110 <span type="species:ncbi:9606">humans</span>
A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans.
###end article-title 120
###begin article-title 121
PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta.
###end article-title 121
###begin article-title 122
PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis.
###end article-title 122
###begin article-title 123
###xml 43 47 <span type="species:ncbi:10090">mice</span>
Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway.
###end article-title 123
###begin article-title 124
Tissue expression of PD-L1 mediates peripheral T cell tolerance.
###end article-title 124
###begin article-title 125
New battlefields for costimulation.
###end article-title 125
###begin article-title 126
Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis.
###end article-title 126
###begin article-title 127
B7-H1 restricts neuroantigen-specific T cell responses and confines inflammatory CNS damage: Implications for the lesion pathogenesis of multiple sclerosis.
###end article-title 127
###begin p 128
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 128
###begin p 129
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: The project was funded by the Deutsche Forschungsgemeinschaft (SFB 581; to RM and HW), by the Gemeinnutzige Hertie-Stiftung (1.01.1/05/10 to RM) and the Thyssen foundation (to R. M. and H. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 129

